REXN: Rexahn Pharmaceuticals, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Rexahn Pharmaceuticals, Inc.

NASDAQ:REXN

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$7.24
Loss Chance
58.0%
1.60JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
AbbVie
NYSE:ABBV
6.05
$215.40
118.14%
ACADIA Pharmaceuticals
NASDAQ:ACAD
5.66
$21.19
20.77%
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Biogen
NASDAQ:BIIB
5.83
$196.97
14.45%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.32
42.58%
Jitta Factors
Growth Opportunity (25)
Recent Business Performance (56)
Financial Strength (33)
Return to Shareholders (1)
Competitive Advantage (15)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
CapExVery High
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
1.60
100.00%
2.21
139.77%
3.06
206.85%
Biotechnology
6.05
118.14%
5.66
20.77%
5.83
14.45%
COMPANY DESCRIPTION
As of November 5, 2020, Rexahn Pharmaceuticals, Inc. was acquired by Ocuphire Pharma, Inc., in a reverse merger transaction. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer. The company’s product pipeline include RX-3117, which is in Phase IIa clinical trials for the treatment of patients with relapsed or refractory metastatic pancreatic cancer, as well as bladder, colon, lung and cervical cancer. It is also developing RX-0301, which is in preclinical development stage for the treatment of hepatocellular carcinoma. Rexahn Pharmaceuticals, Inc. has collaboration agreements with Zhejiang Haichang Biotechnology Co., Ltd.; and BioSense Global LLC. The company is headquartered in Rockville, Maryland.
www.rexahn.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.